Correlation of MLH1 and MGMT methylation levels between peripheral blood leukocytes and colorectal tissue DNA samples in colorectal cancer patients

Li,Xia; Wang,Yibaina; Zhang,Zuoming; Yao,Xiaoping; Ge,Jie; Zhao,Yashuang

doi:10.3892/ol.2013.1543

Correlation of MLH1 and MGMT methylation levels between peripheral blood leukocytes and colorectal tissue DNA samples in colorectal cancer patients

Authors:
- Xia Li
- Yibaina Wang
- Zuoming Zhang
- Xiaoping Yao
- Jie Ge
- Yashuang Zhao
View Affiliations

Affiliations: Department of Epidemiology, Public Health College, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China
Published online on: August 23, 2013 https://doi.org/10.3892/ol.2013.1543
Pages: 1370-1376

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

CpG island methylation in the promoter regions of the DNA mismatch repair gene mutator L homologue 1 (MLH1) and DNA repair gene O6‑methylguanine‑DNA methyltransferase (MGMT) genes has been shown to occur in the leukocytes of peripheral blood and colorectal tissue. However, it is unclear whether the methylation levels in the blood leukocytes and colorectal tissue are correlated. The present study analyzed and compared the levels of MGMT and MLH1 gene methylation in the leukocytes of peripheral blood and colorectal tissues obtained from patients with colorectal cancer (CRC). The methylation levels of MGMT and MLH1 were examined using methylation‑sensitive high‑resolution melting (MS‑HRM) analysis. A total of 44 patients with CRC were selected based on the MLH1 and MGMT gene methylation levels in the leukocytes of the peripheral blood. Corresponding colorectal tumor and normal tissues were obtained from each patient and the DNA methylation levels were determined. The correlation coefficients were evaluated using Spearman's rank test. Agreement was determined by generalized κ‑statistics. Spearman's rank correlation coefficients (r) for the methylation levels of the MGMT and MLH1 genes in the leukocytes of the peripheral blood and normal colorectal tissue were 0.475 and 0.362, respectively (P=0.001 and 0.016, respectively). The agreement of the MGMT and MLH1 gene methylation levels in the leukocytes of the peripheral blood and normal colorectal tissue were graded as fair and poor (κ=0.299 and 0.126, respectively). The methylation levels of MGMT and MLH1 were moderately and weakly correlated between the patient‑matched leukocytes and the normal colorectal tissue, respectively. Blood‑derived DNA methylation measurements may not always represent the levels of normal colorectal tissue methylation.

View Figures

View References

1	Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet. 3:415–428. 2002.PubMed/NCBI
2	Herman JG, Graff JR, Myöhänen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
3	Jones PA and Laird PW: Cancer epigenetics comes of age. Nat Genet. 21:163–167. 1999. View Article : Google Scholar : PubMed/NCBI
4	Baylin SB and Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
5	Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
6	Derks S, Postma C, Moerkerk PT, et al: Promoter methylation precedes chromosomal alterations in colorectal cancer development. Cell Oncol. 28:247–257. 2006.PubMed/NCBI
7	Esteller M: Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer. 36:2294–2300. 2000. View Article : Google Scholar : PubMed/NCBI
8	Frigola J, Solé X, Paz MF, et al: Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet. 14:319–326. 2005. View Article : Google Scholar : PubMed/NCBI
9	Esteller M and Herman JG: Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene. 23:1–8. 2004. View Article : Google Scholar : PubMed/NCBI
10	Pegg AE: Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50:6119–6129. 1990.PubMed/NCBI
11	Povey AC, Badawi AF, Cooper DP, et al: DNA alkylation and repair in the large bowel: animal and human studies. J Nutr. 132:3518S–3521S. 2002.PubMed/NCBI
12	Anacleto C, Leopoldino AM, Rossi B, et al: Colorectal cancer ‘methylator phenotype’: fact or artifact? Neoplasia. 7:331–335. 2005.
13	Anacleto C, Rossi B, Lopes A, et al: Development and application of a multiplex PCR procedure for the detection of DNA methylation in colorectal cancer. Oncol Rep. 13:325–328. 2005.PubMed/NCBI
14	Fox EJ, Leahy DT, Geraghty R, et al: Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer. J Mol Diagn. 8:68–75. 2006. View Article : Google Scholar : PubMed/NCBI
15	Kim YH, Petko Z, Dzieciatkowski S, et al: CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer. 45:781–789. 2006. View Article : Google Scholar : PubMed/NCBI
16	Shen L, Kondo Y, Rosner GL, et al: MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst. 97:1330–1338. 2005. View Article : Google Scholar : PubMed/NCBI
17	Nagasaka T, Goel A, Notohara K, et al: Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. Int J Cancer. 122:2429–2436. 2008. View Article : Google Scholar : PubMed/NCBI
18	Lee KH, Lee JS, Nam JH, et al: Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Langenbecks Arch Surg. 396:1017–1026. 2011. View Article : Google Scholar : PubMed/NCBI
19	Menigatti M, Truninger K, Gebbers JO, Marbet U, Marra G and Schär P: Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene. 28:899–909. 2009. View Article : Google Scholar : PubMed/NCBI
20	Rakyan VK, Down TA, Thorne NP, et al: An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res. 18:1518–1529. 2008.
21	Lofton-Day C, Model F, Devos T, et al: DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 54:414–423. 2008. View Article : Google Scholar : PubMed/NCBI
22	Grützmann R, Molnar B, Pilarsky C, et al: Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One. 3:e37592008.PubMed/NCBI
23	Gazzoli I, Loda M, Garber J, Syngal S and Kolodner RD: A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res. 62:3925–3928. 2002.
24	Miyakura Y, Sugano K, Akasu T, et al: Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin Gastroenterol Hepatol. 2:147–156. 2004. View Article : Google Scholar : PubMed/NCBI
25	Sheng JQ, Zhang H, Ji M, et al: Genetic diagnosis strategy of hereditary non-polyposis colorectal cancer. World J Gastroenterol. 15:983–989. 2009. View Article : Google Scholar : PubMed/NCBI
26	Zhou HH, Yan SY, Zhou XY, et al: MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families. World J Gastroenterol. 14:7329–7334. 2008. View Article : Google Scholar : PubMed/NCBI
27	Psofaki V, Kalogera C, Tzambouras N, et al: Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas. World J Gastroenterol. 16:3553–3560. 2010. View Article : Google Scholar : PubMed/NCBI
28	Candiloro IL and Dobrovic A: Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev Res (Phila). 2:862–867. 2009. View Article : Google Scholar
29	Vineis P, Chuang SC, Vaissière T, et al: DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study. Epigenetics. 6:195–201. 2011. View Article : Google Scholar : PubMed/NCBI
30	Wojdacz TK and Dobrovic A: Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res. 35:e412007. View Article : Google Scholar : PubMed/NCBI
31	Balic M, Pichler M, Strutz J, et al: High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis. J Mol Diagn. 11:102–108. 2009. View Article : Google Scholar
32	Landis JR and Koch GG: The measurement of observer agreement for categorical data. Biometrics. 33:159–174. 1977. View Article : Google Scholar : PubMed/NCBI
33	Esteller M, Sparks A, Toyota M, et al: Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 60:4366–4371. 2000.PubMed/NCBI
34	Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR and Rashid A: CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol. 160:1823–1830. 2002. View Article : Google Scholar : PubMed/NCBI
35	Ahlquist T, Lind GE, Costa VL, et al: Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer. 7:942008. View Article : Google Scholar : PubMed/NCBI
36	Nakagawa H, Nuovo GJ, Zervos EE, et al: Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res. 61:6991–6995. 2001.
37	Meng W, Huebner A, Shabsigh A, Chakravarti A and Lautenschlaeger T: Combined RASSF1A and RASSF2A promoter methylation analysis as diagnostic biomarker for bladder cancer. Mol Biol Int. 2012:7018142012. View Article : Google Scholar : PubMed/NCBI
38	Morandi L, Franceschi E, de Biase D, et al: Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference. BMC Cancer. 10:482010. View Article : Google Scholar : PubMed/NCBI
39	Avraham A, Uhlmann R, Shperber A, et al: Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients. Int J Cancer. 131:E1166–E1172. 2012. View Article : Google Scholar : PubMed/NCBI
40	Kristensen LS, Mikeska T, Krypuy M and Dobrovic A: Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection. Nucleic Acids Res. 36:e422008. View Article : Google Scholar : PubMed/NCBI
41	Lim U, Flood A, Choi SW, et al: Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology. 134:47–55. 2008. View Article : Google Scholar : PubMed/NCBI
42	Pufulete M, Al-Ghnaniem R, Leather AJ, et al: Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology. 124:1240–1248. 2003. View Article : Google Scholar : PubMed/NCBI
43	Lind GE, Thorstensen L, Løvig T, et al: A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer. 3:282004. View Article : Google Scholar : PubMed/NCBI
44	Lee S, Hwang KS, Lee HJ, Kim JS and Kang GH: Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest. 84:884–893. 2004. View Article : Google Scholar : PubMed/NCBI
45	Ally MS, Al-Ghnaniem R and Pufulete M: The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors. Cancer Epidemiol Biomarkers Prev. 18:922–928. 2009. View Article : Google Scholar : PubMed/NCBI
46	Moore LE, Pfeiffer RM, Poscablo C, et al: Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol. 9:359–366. 2008. View Article : Google Scholar : PubMed/NCBI
47	Wang L, Aakre JA, Jiang R, et al: Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA. J Thorac Oncol. 5:778–785. 2010. View Article : Google Scholar : PubMed/NCBI
48	Hsiung DT, Marsit CJ, Houseman EA, et al: Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 16:108–114. 2007. View Article : Google Scholar : PubMed/NCBI
49	Widschwendter M, Apostolidou S, Raum E, et al: Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One. 3:e26562008. View Article : Google Scholar : PubMed/NCBI
50	McKay JA, Xie L, Harris S, Wong YK, Ford D and Mathers JC: Blood as a surrogate marker for tissue-specific DNA methylation and changes due to folate depletion in post-partum female mice. Mol Nutr Food Res. 55:1026–1035. 2011. View Article : Google Scholar : PubMed/NCBI
51	Christensen BC, Houseman EA, Marsit CJ, et al: Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 5:e10006022009. View Article : Google Scholar : PubMed/NCBI
52	Walsh CP and Bestor TH: Cytosine methylation and mammalian development. Genes Dev. 13:26–34. 1999. View Article : Google Scholar : PubMed/NCBI